European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical SciencesTriple Negative Breast NeoplasmsAnimalsFemaleDoxorubicinExtracellular Vesicles
Synergistic chemoimmunotherapy using pirarubicin-loaded tumor-derived extracellular vesicles for triple-negative breast cancer (TNBC).
Quanwu Sun, Shenhan Yu, Rong Shi, Meng Xu, Peilan Ma, Feng Yan Lv
Published: 202510.1016/j.ejps.2025.107331
Abstract
Triple-negative breast cancer (TNBC) has an extremely poor clinical prognosis due to the lack of effective therapeutic targets and high heterogeneity. In this study, we developed a synergistic chemoimmunotherapy based on tumor-derived extracellular v…
Preview only. Read the full abstract at the source